Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

658
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
658
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

2.1K
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.1K
Hypertension I: Introduction01:28

Hypertension I: Introduction

615
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
615
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

395
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
395
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

318
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
318

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gender, racial and ethnic diversity in US academic paediatric faculty: trends over 55 years.

BMJ leader·2026
Same author

Hypogammaglobulinemia and B cell repopulation after rituximab in childhood nephrotic syndrome.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Precision for all children: embedding equity into precision medicine for children.

BMJ paediatrics open·2026
Same author

Infectious complications in paediatric kidney transplantation: prevention and management.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Kidney Transplantation in Childhood-Onset ANCA-Associated Vasculitis: Long-Term Outcomes and Prognostic Factors.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Practice variation in the use of steroid-sparing therapies in childhood steroid-sensitive nephrotic syndrome: results from a prospective cohort study.

Pediatric nephrology (Berlin, Germany)·2025

Related Experiment Video

Updated: Dec 31, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.1K

Hyperuricemia and Hypertension: Links and Risks.

Douglas J Stewart1, Valerie Langlois1,2, Damien Noone1,2

  • 1Division of Nephrology, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.

Integrated Blood Pressure Control
|January 11, 2020
PubMed
Summary

High uric acid levels (hyperuricemia) are linked to cardiovascular risks, especially hypertension in adolescents. More research is needed to confirm causality and the effectiveness of uric acid-lowering therapies.

Keywords:
cardiovascularchronic kidney diseasehypertensionhyperuricemiaurate

More Related Videos

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril
10:02

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril

Published on: October 3, 2020

4.3K
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.7K

Related Experiment Videos

Last Updated: Dec 31, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.1K
Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril
10:02

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril

Published on: October 3, 2020

4.3K
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.7K

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Metabolic Disorders

Background:

  • Hyperuricemia is associated with increased cardiovascular risk, particularly hypertension.
  • This link appears stronger in pediatric populations.
  • Uric acid's dual role as an extracellular antioxidant and intracellular pro-inflammatory agent contributes to microvascular injury.

Purpose of the Study:

  • To review current data on the relationship between hyperuricemia and hypertension.
  • To highlight the need for robust prospective studies.
  • To assess the current evidence for uric acid-lowering therapies in hypertension prevention.

Main Methods:

  • Review of existing epidemiological and clinical studies.
  • Analysis of proposed mechanisms linking uric acid to hypertension.
  • Identification of research gaps and limitations.

Main Results:

  • Chronic hyperuricemia may lead to microvascular injury and afferent arteriolopathy, contributing to resistant hypertension.
  • Establishing direct causality is challenging due to confounding factors like body mass index.
  • Current evidence supporting uric acid-lowering therapies for hypertension risk mitigation is limited.

Conclusions:

  • Further large-scale prospective randomized controlled trials are essential to establish causality and therapeutic efficacy.
  • The role of hyperuricemia in hypertension requires more definitive investigation.
  • Current data does not strongly support using uric acid-lowering therapies to prevent hypertension.